Anne‐Floor B.E. Quast

Subcutaneous or Transvenous Defibrillator Therapy

Reinoud E. Knops, Louise R.A. Olde Nordkamp, Peter-Paul Delnoy et al. · New England Journal of Medicine · 2020 · 446 citations · Full text

A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score

Anne‐Floor B.E. Quast, Sarah W.E. Baalman, Tom F. Brouwer et al. · Heart Rhythm · 2018 · 139 citations

Electrophysiological Evaluation, Predict Defibrillation Success, Cardiovascular Disease +8

Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator

Fleur V.Y. Tjong, Tom F. Brouwer, Brendan Koop et al. · JACC. Clinical electrophysiology · 2017 · 80 citations · Full text

Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator

Tom F. Brouwer, Marc A. Miller, Anne‐Floor B.E. Quast et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 68 citations

Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing

Anne‐Floor B.E. Quast, Sarah W.E. Baalman, Timothy R. Betts et al. · American Heart Journal · 2019 · 58 citations

Heart Failure, Praetorian-dft Trial, Device Therapy +7